Download PDF
Z Gastroenterol 2001; 39(3): 225-237
DOI: 10.1055/s-2001-11772
Übersicht
© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New York

Hepatotoxizität von Arzneimitteln pflanzlichen Ursprungs

F. Stickel1 , H. K. Seitz2 , E. G. Hahn1 , D. Schuppan1
  • Medizinische Klinik I mit Poliklinik, Friedrich-Alexander-Universität Erlangen-Nürnberg (Direktor: Prof. Dr. E. G. Hahn)
  • , Medizinische Klinik, Krankenhaus Salem, Akademisches Lehrkrankenhaus der Universität Heidelberg (Direktor: Prof. Dr. H. K. Seitz)
Further Information

Publication History

2.6.2000

3.7.2000

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

Pflanzliche Medikamente sind weit verbreitet und enthalten häufig pharmakologisch hoch aktive Substanzen. In letzter Zeit häufen sich Berichte über eine Hepatotoxizität pflanzlicher Medikamente mit leichten Leberwertveränderungen bis zu schwersten chronischen Lebererkrankungen und Leberversagen.

Eine Hepatotoxizität chinesischer Kräutertees wurde unter anderem im Zusammenhang mit der Behandlung von Hautekzemen beobachtet, die verantwortlichen Substanzen sind bisher allerdings unbekannt. Die akute Lebervenen-Verschlusskrankheit wird von in vielen Pflanzen enthaltenen Pyrrolizidinalkaloiden hervorgerufen. Teucrium chamaedrys, auch Edelgamander genannt, kann zu Hepatitis und Leberzirrhose führen. Erhebliche Leberschäden wurden mit Kreosoth in Verbindung gebracht. Vor kurzem konnte auch Schöllkraut, das unter anderem zur Behandlung von Gallenleiden und Dyspepsie eingesetzt wurde, als Auslöser einer cholestatischen Hepatitis identifiziert werden. Hepatotoxische Reaktionen wurden auch nach der Einnahme von Atractylis gummifera, Callilepsis laureola, Senna, Kavapyron und Pulegium beschrieben.

Ziel dieser Übersicht ist es, auf die wesentlichen pflanzlichen, potenziell hepatotoxischen Substanzen hinzuweisen, deren Toxizität - soweit bekannt - zu skizzieren und damit das Bewusstsein für pflanzliche Pharmaka als mögliche Ursache von Leberschäden zu schärfen.

Hepatotoxicity of herbal remedies

Herbal drugs are widely used and often contain highly active pharmacological compounds. Recently, reports have mounted about hepatotoxicity of herbal remedies which ranges from mild liver enzyme alterations to chronic liver disease and liver failure.

Hepatotoxicity of Chinese herbs has been recognized, e. g. during treatment of patients with atopic eczema. However, the toxic compounds remain to be determined. Hepatic veno-occlusive disease may result from pyrrolizidine alkaloids which are contained in numerous plants worldwide. Teucrium chamaedrys, commonly referred to as germander, may cause hepatitis and even liver cirrhosis. Significant hepatotoxicity has also been observed after the ingestion of chaparral. Recently, greater celandine, which is widely used for biliary disorders and dyspepsia, was identified as a cause of cholestatic hepatitis. Hepatotoxic reactions have also been observed after the ingestion of Atractylis gummifera, Callilepsis laureola, Senna, Kavapyrone and Pulegium.

The aim of this review is to summarize potentially hepatotoxic herbal remedies, to further elucidate their mechanisms of toxicity and thereby underline the likelihood of plants to be the cause of liver damage.

Schlüsselwörter

Hepatotoxizität - Pflanzliche Arzneimittel - Chinesische Kräuter - Gamander - Phytopharmaka - Pyrrolizidinalkaloide - Schöllkraut - Senna - Sho-saiko-to - Alternative Medizin

Key words

Hepatotoxicity - Botanicals - Chinese Herbs - Germander - Phytotherapy - Pyrrolizidine Alkaloids - Greater Celandine - Senna - Sho-saiko-to - Alternative Medicine

Literatur

  • 1 Breevort P. The U.S. botanical market - an overview.  Herbalogramm. 1996;  36 49-57
    Google Scholar
  • 2 Corbin W inslow L, Kroll D J. Herbs as Medicine.  Arch Intern Med. 1998;  158 2192-2199
    Google Scholar
  • 3 Moore J, Phipps K, Marcer D. Why do people seek treatment by alternative medicine?.  BMJ. 1985;  290 28-29
    Google Scholar
  • 4 Brown J S, Marcy S A. The use of botanicals for health purposes by members of a prepaid health plan.  Res Nurs Health. 1991;  14 339-350
    Google Scholar
  • 5 Sherlock S, Dooley J. Drugs and the liver. Sherlock S, Dooley J Diseases of the liver and the biliary system Oxford, Blackwell Science 10th edition,; 1997: 337-369
    Google Scholar
  • 6 Nebert D W, Nelson D R, Coon M J. et al . The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature.  DNA Cell Biol. 1991;  10 1-14
    Google Scholar
  • 7 Carlsson C. Herbs and hepatitis.  Lancet. 1990;  336 1068
    Google Scholar
  • 8 http://www. bfarm.de/de_ver/arzneimittel/weiteres.html. 
    Google Scholar
  • 9 Tyler V E. What pharmacists should know about herbal remedies.  J Am Pharm Assoc. 1996;  36 29-37
    Google Scholar
  • 10 Sheehan M P, Rustin M HA, Atherton D J. et al . Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis.  Lancet. 1992;  340 13-17
    Google Scholar
  • 11 Sheehan M P, Atherton D J. A controlled trial of traditional Chinese medicinal plants in widespread non-exsudative atopic eczema.  Br J Dermatol. 1992;  126 179-184
    Google Scholar
  • 12 Davies E G, Pollock I, Steel H M. Chinese herbs for eczema.  Lancet. 1990;  336 38
    Google Scholar
  • 13 Graham-Brown R. Toxicity of Chinese herbal remedies.  Lancet. 1992;  346 674
    Google Scholar
  • 14 Perharic-Walton L, Murray V. Toxicity of traditional Chinese herbal remedies.  Lancet. 1992;  346 674
    Google Scholar
  • 15 Kane J A, Kane S P, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components.  Gut. 1995;  36 146-147
    Google Scholar
  • 16 Yoshida E M, McLean C A, Cheng E S. et al . Chinese herbal medicine, fulminant hepatitis and liver transplantation.  Am J Gastroenterol. 1996;  12 2647-2648
    Google Scholar
  • 17 Chan T YK, Chan J CN, Tomlinson B, Critchley A JH. Chinese herbal medicines revisited: A Hong Kong perspective.  Lancet. 1993;  342 1532-1534
    Google Scholar
  • 18 Galloway J H, Marsh I D, Bittiner I D. et al . Chinese herbs for eczema, the active compound?.  Lancet. 1991;  337 566
    Google Scholar
  • 19 Woolf G M, Petrovic L M, Roiter S E. et al . Acute hepatitis associated with the Chinese herbal product Jin Bu Huan.  Ann Intern Med. 1994;  10 729-735
    Google Scholar
  • 20 Piciotto A, Campo N, Brizzolara R. et al . Chronic hepatitis induced by Jin Bu Huan.  J Hepatol. 1998;  28 165-167
    Google Scholar
  • 21 Tyler V E. The honest herbal: A sensible guide to the use of herbs and related remedies. New York, Pharmaceutical Products Press, 3rd edition 1993: 119-121
    Google Scholar
  • 22 Mowrey D B. The major scientific breakthrough of the 90’s. Reducing body fat through thermogenics.  Health Store News. 1994;  11 1-4
    Google Scholar
  • 23 Nadir A, Agrawal S, King P D, Marshall J B. Acute hepatitis associated with the use of a Chinese herbal product, Ma-Huang.  Am J Gastroenterol. 1996;  91 1436-1438
    Google Scholar
  • 24 Benichou C. Criteria of drug-induced liver disorders: Reports of an international consensus meeting.  J Hepatol. 1990;  11 272-276
    Google Scholar
  • 25 Huxtable R J. The myth of beneficent nature: The risks of herbal preparations.  Ann Intern Med. 1992;  117 165-166
    Google Scholar
  • 26 Wu T N, Yang K C, Lai J S. et al . Lead poisoning caused by contaminated Cordyceps, a Chinese herbal preparation.  Sci Total Environ. 1996;  182 193-195
    Google Scholar
  • 27 Batey R G, Bensoussan A, Fan Y ang Yi, Bollipo S, Hossain M. Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C.  J Gastroenterol Hepatol. 1998;  13 244-247
    Google Scholar
  • 28 Miyahara M, Tatsumi Y. Suppression of lipid peroxidation by sho-saiko-to and its components in rat liver subcellular membranes.  Yakugaku Zasshi. 1990;  110 407-413
    Google Scholar
  • 29 Sakaguchi S, Tsutsumi E, Yokota K. Preventive effect of a traditional Chinese medicine (sho-saiko-to) against oxygen toxicity and membrane damage during endotoxemia.  Biol Pharm Bull. 1993;  16 782-786
    Google Scholar
  • 30 Sakaguchi S, Tsutsumi E, Yokota K. Defensive effects of a traditional Chinese medicine (sho-saiko-to) against metabolic disorders during endotoxemia.  Biol Pharm Bull. 1994;  17 232-236
    Google Scholar
  • 31 Yano H, Mizoguchi H, Fukuda K. et al . The herbal medicine sho-saiko-to inhibits proliferation of cancer cells by inducing apoptosis and arrest at the G0/G1 phase.  Cancer Res. 1994;  54 448-454
    Google Scholar
  • 32 Matsusaki Y, Kurokawa N, Terai S. et al . Cell death induced by baicalein in human hepatocellular carcinoma cells.  Jpn J Cancer Res. 1996;  87 170-177
    Google Scholar
  • 33 Miyamura M, Ono M, Kyotani S, Nishioka Y. Effect of sho-saiko-to extract on fibrosis and regeneration of the liver in rats.  J Pharm Pharmacol. 1998;  5097-5105
    Google Scholar
  • 34 Sakaida I, Matsumura Y, Akiyama S. et al . Herbal medicine sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.  J Hepatol. 1998;  28 298-306
    Google Scholar
  • 35 Okah H, Yamamoto S, Kuroki T. et al . Prospective study of chemoprevention of hepatocellular carcinoma with sho-saiko-to (TJ-9).  Cancer. 1995;  76 743-749
    Google Scholar
  • 36 Kayano K, Sakaida I, Uchida K, Okita K. Inhibitory effects of the herbal medicine sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expression in cultured rat hepatic stellate cells.  J Hepatol. 1998;  29 642-649
    Google Scholar
  • 37 Shimizu I, Ma Y R, Mizobuchi Y. et al . UEffects of sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats.  Hepatology. 1999;  29 149-160
    Google Scholar
  • 38 Geerts A, Rogiers V. Sho-saiko-to: The right blend of traditional oriental medicine and liver cell biology.  Hepatology. 1999;  29 282-284
    Google Scholar
  • 39 Dehmlow C, Erhard J, De Groot H. Inhibition of Kupffer cell functions as an explantation for the hepatoprotective properties of silibinin.  Hepatology. 1996;  23 749-754
    Google Scholar
  • 40 Boigk G, Stroedter L, Herbst H. et al . Silymarin retards hepatic collagen accumulation in early and advanced biliary fibrosis secondary to bile duct obliteration in the rat.  Hepatology. 1997;  26 643-649
    Google Scholar
  • 41 Itoh S, Marutani K, Nishijima T. Liver injuries induced by herbal medicine, sho-saiko-to (xiao-chai-hu-tang).  Dig Dis Sci. 1995;  8 1845-1848
    Google Scholar
  • 42 Kamiyama T, Nouchi T, Kojima S. et al . Autoimmune hepatitis triggered by administration of an herbal medicine.  Am J Gastroenterol. 1997;  92 703-704
    Google Scholar
  • 43 Wilmot F C, Robertson G W. Senecio disease or cirrhosis of the liver due to Senecio poisoning.  Lancet. 1920;  II 828-829
    Google Scholar
  • 44 Selzer G, Parker R GF. Senecio poisoning exhibiting as Chiari’s syndrome.  Am J Pathol. 1951;  27 885-907
    Google Scholar
  • 45 Bras G, Jeliffe D B, Stuart K L. Veno-occlusive disease of the liver with non-portal type of cirrhosis, occurring in Jamaica.  AMA Arch Pathol. 1954;  57 285-300
    Google Scholar
  • 46 Mohabat O, Srivastava R N, Younos M S. et al . An outbreak of hepatic veno-occlusive disease in North-Western Afghanistan.  Lancet. 1976;  2 269-271
    Google Scholar
  • 47 Tandon B N, Tandon R K, Tandon H D Narndranathan M. An epidemic of veno-occlusive disease of liver in Central India.  Lancet. 1976;  2 271-272
    Google Scholar
  • 48 Stillman A S, Huxtable R J, Consroe P, Kohnen P, Smith S. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona.  Gastroenterology. 1977;  73 349-352
    Google Scholar
  • 49 Roitman J N. Comfrey and liver damage.  Lancet. 1981;  1 944
    Google Scholar
  • 50 Ridker P M, Ohkuma S, McDermott W V, Trey C, Huxtable R J. Hepatic venoocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements.  Gastroenterology. 1985;  88 1050-1054
    Google Scholar
  • 51 Huxtable R J, Lüthy J, Zweifel U. Toxicity of comfrey-pepsin preparations.  N Engl J Med. 1986;  315 1095
    Google Scholar
  • 52 Weston C FM, Cooper B T, Davies J D. Veno-occlusive disease of the liver secondary to ingestion of comfrey.  BMJ. 1987;  295 183
    Google Scholar
  • 53 Bach N, Thung S N, Schaffner F. Comfrey herb tea-induced hepatic veno-occlusive disease.  Am J Med. 1989;  87 97-99
    Google Scholar
  • 54 Monographie der Kommision E, vom BAnz Nr 138 vom 27.07.1990. 
    Google Scholar
  • 55 Huxtable R J. New aspects of the toxicology and pharmacology of pyrrolizidine alkaloids.  Gen Pharmacol. 1979;  10 159-167
    Google Scholar
  • 56 Couet C E, Hopley J, Hanley A B. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.  Toxicon. 1996;  34 1058-1061
    Google Scholar
  • 57 Mattocks A R. Chemistry and toxicology of pyrrolizidine alkaloids. London, Academic Press; 1986
    Google Scholar
  • 58 Sherlock S. Noncirrhotic extrahepatic and intrahepatic portal hypertension.  Semin Liver Dis. 1982;  2 202-210
    Google Scholar
  • 59 Sperl W, Stuppner H, Gassner J. et al . Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea.  Europ J Pediatr. 1995;  154 112-116
    Google Scholar
  • 60 Zimmermann H J, Lewis J H. Chemical and toxin-induced liver disease.  Gastroenterol Clin North Am. 1995;  24 739
    Google Scholar
  • 61 Diaz D, Ferroudji S, Heran B. Hépatite aigue à la Germandrée petit-chêne.  Gastroenterol Clin Biol. 1993;  16 1006-1007
    Google Scholar
  • 62 Larrey D, Vial T, Pauwels A. et al . Hepatitis after Germander (Teucrium chamaedrys) adminstration: Another instance of herbal medicine hepatotoxicity.  Ann Intern Med. 1992;  117 129-132
    Google Scholar
  • 63 Mostefa-Kara N, Pauwels A, Pines E, Biour C, Levy V G. Fatal hepatitis after herbal tea.  Lancet. 1992;  340 674
    Google Scholar
  • 64 Larrey D, Pageaux G P. Hepatotoxicity of herbal remedies and mushrooms.  Semin Liver Dis. 1995;  15 183-188
    Google Scholar
  • 65 Ben Y ahia M, Mavier P, Matreau J M. Hépatite chronique active et cirrhose induites par la Germandrée petit-chêne: A propos de trois cas.  Gastroenterol Clin Biol. 1993;  17 959-962
    Google Scholar
  • 66 Dao T, Peytier A, Galateau F, Valla A. Hépatite chronique cirrhogene a la germandrée petit-chene.  Gastroenterol Clin Biol. 1993;  17 609-610
    Google Scholar
  • 67 Savona G, Garcia-Alvarez M C, Rodriguez B. Dihydroteugin, a neo-clerodane diterpenoid from Teucrium chamaedrys.  Phytochemistry. 1982;  21 721-723
    Google Scholar
  • 68 Rodriguez M C, Barluenga J, Pascual C. et al . Neo-clerodane diterpenoids from Teucrium chamaedrys: The identity of teucrin B with dihydroteugin.  Phytochemistry. 1984;  23 2960-2961
    Google Scholar
  • 69 Piozzi F, Rodriguez B, Savona G. Advances in the chemistry of the furanoditerpenoids from Teucrium species.  Heterocycles. 1987;  25 807-841
    Google Scholar
  • 70 Maronpot R R, Giles H D, Dykes D J, Irwin R D. Furan-induced hepatic cholangiocarcinomas in Fisher 344 rats.  Toxicol Pathol. 1991;  19 561-570
    Google Scholar
  • 71 Elmore L W, Sirica A E. ‘Intestinal-type’ of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan.  Cancer Res. 1993;  53 254-259
    Google Scholar
  • 72 Mitchell J R, Potter W Z, Hinson J A, Jollow D J. Hepatic necrosis caused by furosemide.  Nature. 1974;  251 508-511
    Google Scholar
  • 73 Ramsdell H S, Parkinson A, Eddy A C, Eaton D L. Bioactivation of aflatoxin B1 by human liver microsomes. Role of cytochrome P 450 IIIA enzymes.  Toxicol Appl Pharmacol. 1991;  108 436-447
    Google Scholar
  • 74 Labbe G, Descatoire V, Beaune P h. et al . Suicide inactivation of cytochrome P 450 by methoxalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.  J Pharmacol Exp Ther. 1989;  250 1034-1042
    Google Scholar
  • 75 Loeper J, Descatoire V, Letteron P. et al . Hepatotoxicity of germander in mice.  Gastroenterology. 1994;  106 464-472
    Google Scholar
  • 76 Kouzi S A, McMurty R J, Nelson S D. Hepatotoxicity of germander (Teucrium chamedrys L.) and one of its constituent neoclerodane diterpenes, teucrin A in the mouse.  Chem Res Toxicol. 1994;  7 850-856
    Google Scholar
  • 77 Lekehal M, Pessayre D, Lereau J M. et al . Hepatotoxicity of the herbal medicine, germander. Metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes.  Hepatology. 1996;  24 212-218
    Google Scholar
  • 78 Fau D, Lekehal M, Farrell G. et al . Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes.  Gastroenterology. 1997;  113 1334-1346
    Google Scholar
  • 79 Mattei A, Rucay P, Samuel D. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration (letter).  J Hepatol. 1995;  22 597
    Google Scholar
  • 80 Strahl S, Ehret V, Dahm H H, Maier K P. Nekrotisierende Hepatitis nach Einnahme pflanzlicher Heilmittel.  Dtsch Med Wochenschr. 1998;  123 1410-1414
    Google Scholar
  • 81 Greving I, Meister V, Monnerjahn C, Müller K M, May B. Chelidonium majus: A rare reason for severe hepatotoxic reaction.  Pharmacoepidemiol Drug Safety. 1998;  7 S66-69
    Google Scholar
  • 82 Benninger J, Schneider H T, Schuppan D, Kirchner T, Hahn E G. Acute hepatitis induced by greater celandine (chelidonium majus).  Gastroenterology. 1999;  117 1234-1237
    Google Scholar
  • 83 Zimmerman H J, Maddrey W C. Toxic and drug-induced hepatitis. Schiff L, Schiff ER Diseases of the liver Philadelphia, Lippincott; 1993 Vol. 1, 7th ed: 707-783
    Google Scholar
  • 84 Sheikh N M, Philen R M, Love L A. Chaparral-associated hepatotoxicity.  Arch Intern Med. 1997;  157 913-919
    Google Scholar
  • 85 Kassler W J, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients.  Arch Intern Med. 1991;  2281-2288
    Google Scholar
  • 86 Schiano T. Liver injury from herbs and other botanicals. In: Gitlin N Clinics in Liver Disease Chicago, WB Saunders; 1998 2: 607-630
    Google Scholar
  • 87 Gordon D F, Rosenthal G, Hart J, Sirota R, Baker A L. Chaparral ingestion: The broadening spectrum of liver injury caused by herbal medications.  JAMA. 1995;  273 489-490
    Google Scholar
  • 88 Katz M, Saibil F. Herbal hepatitis: Subacute hepatic necrosis secondary to chaparral leaf.  J Clin Gastroenterol. 1990;  12 203-306
    Google Scholar
  • 89 Capdevila J, Gil L, Orellana M. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism.  Arch Biochem Biophys. 1988;  261 257-263
    Google Scholar
  • 90 Agarwal R, Wang Z Y, Bik D P, Mukhtar H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.  Drug Metab Dispos. 1991;  19 620-624
    Google Scholar
  • 91 Alderman S, Kailas S, Goldfarb S. et al . Cholestatic hepatitis after ingestion of Chaparral leaf: Confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy.  J Clin Gastroenterol. 1994;  19 242-247
    Google Scholar
  • 92 Larrey D. Hepatotoxicity of herbal remedies.  J Hepatol. 1997;  26 47-54
    Google Scholar
  • 93 Obatomi D K, Brant S, Anthony-Pillai V, Bach P H. Toxicity of atractylosides in precision-cut rat and porcine renal and hepatic tissue slices.  Tox Appl Pharm. 1998;  148 35-45
    Google Scholar
  • 94 Mokhobo K P. Herb use and necro-degenerative hepatitis.  S Afr Med J. 1976;  50 1096-1069
    Google Scholar
  • 95 Anderson I B, Mullen W H, Meeker J E. et al . Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature.  Ann Intern Med. 1996;  124 726-734
    Google Scholar
  • 96 Gordon W P, Huitric A C, Seth C L, McClanahan R H, Nelson S D. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.  Drug Metab Dispos. 1987;  15 589-594
    Google Scholar
  • 97 Thomassen D, Slattery J T, Nelson S D. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: Roles of glutathione.  J Pharmacol Exp Ther. 1990;  253 567-572
    Google Scholar
  • 98 Thomassen D, Knebel N, Slattery J T, McClanahan R H, Nelson S D. Reactive intermediates in the oxidation of menthofuran by cytochromes P-450.  Chem Res Toxicol. 1992;  5 123-130
    Google Scholar
  • 99 Fleig W W, Morgan M Y, Hölzer M A and a European multicenter study group: The ayurvedic drug LIV. 52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial.  J Hepatol. 1997;  26 (Suppl. 1) A127
    Google Scholar
  • 100 Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of prostata.  Ann Intern Med. 1997;  127 169
    Google Scholar
  • 101 Beuers U, Spengler U, Pape G. Hepatitis after chronic abuse of senna.  Lancet. 1991;  337 372-373
    Google Scholar
  • 102 Streicher E. Akutes Nierenversagen und Ikterus nach einer Vergiftung mit Rhabarberblättern.  Dtsch Med Wochenschr. 1964;  89 2379-2381
    Google Scholar
  • 103 Anonymous: Kava.  Lancet. 1988;  258-259
    Google Scholar
  • 104 Colin-Jones D G, Harvey J. Mistletoe hepatitis.  BMJ. 1982;  284 744
    Google Scholar
  • 105 McGregor F B, Abernethy V E, Dahabra S, Cobden I, Hayes P C. Hepatotoxicity of herbal remedies.  BMJ. 1989;  299 1156-1157
    Google Scholar
  • 106 Mullins M E, Horowitz B Z. The case of the salad shooters: Intravenous injection of wild lettuce extract.  Vet Hum Toxicol. 1998;  40 290-291
    Google Scholar

Anschrift für die Verfasser

Prof. Dr. Dr. D. Schuppan

Medizinische Klinik I und Poliklinik
Universität Erlangen-Nürnberg

Krankenhausstraße 12

91054 Erlangen

Email: detlef.schuppan@med1.imed.uni-erlangen.de

      >